Sino Medical Sciences Technology, Inc. (688108) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Poor Management Efficiency with a low ROCE of 0%

The company has reported losses and also has negative networth. This is not a good sign for the investors. Either company will have to raise fresh capital or report profits to sustain going forward

Poor long term growth as Net Sales has grown by an annual rate of 3.76% and Operating profit at -164.37% over the last 5 years

Positive results in Mar 25

With ROE of -0.06%, it has a risky valuation with a 8.83 Price to Book Value

Market Beating Performance

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

CNY 7,897 Million (Large Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.11

Return on Equity

-0.06%

Price to Book

8.83

Revenue and Profits:

Net Sales:

138 Million

(Quarterly Results - Jun 2025)

Net Profit:

10 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-50.83%

6 Months

52.48%

1 Year

62.33%

2 Years

26.79%

3 Years

160.44%

4 Years

112.63%

5 Years

11.99%

Sino Medical Sciences Technology, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

3.76%

EBIT Growth (5y)

-164.37%

EBIT to Interest (avg)

-61.23

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.15

Sales to Capital Employed (avg)

0.36

Tax Ratio

50.89%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

8.83

EV to EBIT

-896.74

EV to EBITDA

84.56

EV to Capital Employed

9.84

EV to Sales

16.22

PEG Ratio

Dividend Yield

ROCE (Latest)

-1.10%

ROE (Latest)

-0.06%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 38.55% vs -28.19% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 288.89% vs 80.00% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "138.00",
          "val2": "99.60",
          "chgp": "38.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "37.70",
          "val2": "23.60",
          "chgp": "59.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.20",
          "val2": "1.30",
          "chgp": "-7.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "10.50",
          "val2": "2.70",
          "chgp": "288.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "92.20%",
          "val2": "-13.60%",
          "chgp": "10.58%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 33.46% vs 77.51% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 91.01% vs 74.96% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "455.10",
          "val2": "341.00",
          "chgp": "33.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "57.40",
          "val2": "12.90",
          "chgp": "344.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "5.80",
          "val2": "3.90",
          "chgp": "48.72%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-3.90",
          "val2": "-43.40",
          "chgp": "91.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-99.20%",
          "val2": "-218.40%",
          "chgp": "11.92%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

138.00

99.60

38.55%

Operating Profit (PBDIT) excl Other Income

37.70

23.60

59.75%

Interest

1.20

1.30

-7.69%

Exceptional Items

0.00

Consolidate Net Profit

10.50

2.70

288.89%

Operating Profit Margin (Excl OI)

92.20%

-13.60%

10.58%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is 38.55% vs -28.19% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 288.89% vs 80.00% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

455.10

341.00

33.46%

Operating Profit (PBDIT) excl Other Income

57.40

12.90

344.96%

Interest

5.80

3.90

48.72%

Exceptional Items

0.00

Consolidate Net Profit

-3.90

-43.40

91.01%

Operating Profit Margin (Excl OI)

-99.20%

-218.40%

11.92%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 33.46% vs 77.51% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 91.01% vs 74.96% in Dec 2023

All Annual Results

Company CV

About Sino Medical Sciences Technology, Inc.

Sino Medical Sciences Technology, Inc.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available